the stock price is reflecting the credibility of the significant discovery in lung cancer, which Mr. Klemp
has now determined is not so significant or as significant as developments with the FDA as he stated in the CC was the most important new development.
The indication for lung cancer treatment is unclear, as according to their website they have not pursued anything in lung cancer treatment.
Lung cancer is not mentioned anywhere.
The other 99 per cent of the CC was rehashing old news as they felt the need to update shareholders.
They also felt the need to get the stock price up for the offering, which was of more paramount importance than the notion they were thinking of us in a benevolent way.
News 
Market Data 
Discover 
